One thing I’ll say, which may come off as harsh,

One thing I’ll say, which may come off as harsh, is that Joe and Generex need to stop pointing at excuses and instead lead with strength. From the outside, Generex’s shareholders are unsure of what the heck this company is doing, or if they are still alive. Shareholders don’t want the leaders of the company to be imagined as in a fetal position moaning about mRNA vaccines or the government. Stand tall, honestly publish or tout “the company’s” data that too date no one has seen, file with the SEC on time, and right this ship.